Celularity Inc SEC filings CELU

Celularity Inc has 560 filings in SEC EDGAR's recent list, going back to Nov 5, 2018. Its latest annual report, Form 10-K, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 20, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (other events). The company's fiscal year ends on December 31.

Celularity Inc SEC filings
Form Description Filed Period
10-Q Quarterly report Oct 20, 2026 Jun 30, 2026
10-Q Quarterly report Sep 29, 2026 Mar 31, 2026
10-Q Quarterly report Nov 14, 2025 Sep 30, 2025
10-Q Quarterly report Aug 29, 2025 Jun 30, 2025
10-Q Quarterly report Aug 29, 2025 Mar 31, 2025
10-Q Quarterly report Dec 6, 2024 Sep 30, 2024
10-Q Quarterly report Nov 7, 2024 Jun 30, 2024
10-Q Quarterly report Oct 16, 2024 Mar 31, 2024
10-Q Quarterly report Jan 3, 2024 Sep 30, 2023
10-Q Quarterly report Aug 14, 2023 Jun 30, 2023
10-Q Quarterly report May 22, 2023 Mar 31, 2023
10-Q Quarterly report Nov 10, 2022 Sep 30, 2022
10-Q Quarterly report Aug 9, 2022 Jun 30, 2022
10-Q Quarterly report May 16, 2022 Mar 31, 2022
10-Q Quarterly report Nov 12, 2021 Sep 30, 2021
10-Q Quarterly report Aug 19, 2021 Jun 30, 2021
10-Q Quarterly report May 24, 2021 Mar 31, 2021
10-Q Quarterly report Nov 16, 2020 Sep 30, 2020
10-Q Quarterly report Aug 13, 2020 Jun 30, 2020
10-Q Quarterly report May 15, 2020 Mar 31, 2020
10-Q Quarterly report Nov 13, 2019 Sep 30, 2019
10-Q Quarterly report Aug 7, 2019 Jun 30, 2019

Showing 22 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
CELU (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Florham Park, NJ
SEC filer status
, Emerging growth company
SEC CIK
1752828
Former names
GX Acquisition Corp. (until Jul 19, 2021)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.